|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA: Cancer J Clin. 68:7–30. 2018.PubMed/NCBI
|
|
2
|
Tsai WL and Chung RT: Viral
hepatocarcinogenesis. Oncogene. 29:2309–2324. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arzumanyan A, Reis HM and Feitelson MA:
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular
carcinoma. Nature reviews. Cancer. 13:123–135. 2013.PubMed/NCBI
|
|
4
|
Stickel F: Alcoholic cirrhosis and
hepatocellular carcinoma. Adv Exp Med Biol. 815:113–130. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kew MC: Aflatoxins as a cause of
hepatocellular carcinoma. J Gastrointestin Liver Dis. 22:305–310.
2013.PubMed/NCBI
|
|
6
|
Di Bisceglie AM: Hepatitis B and
hepatocellular carcinoma. Hepatology. 49:S56–S60. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhu RX, Seto WK, Lai CL and Yuen MF:
Epidemiology of Hepatocellular carcinoma in the asia-pacific
region. Gut Liver. 10:332–339. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kanda T, Goto T, Hirotsu Y, Moriyama M and
Omata M: Molecular mechanisms driving progression of liver
cirrhosis towards hepatocellular carcinoma in chronic hepatitis B
and C infections: A review. Int J Mol Sci. 20:13582019. View Article : Google Scholar
|
|
9
|
Daher S, Massarwa M, Benson AA and Khoury
T: Current and future treatment of hepatocellular carcinoma: An
updated C omprehensive review. J Clin Transl Hepatol. 6:69–78.
2018.PubMed/NCBI
|
|
10
|
Shindoh J, Hasegawa K, Inoue Y, Ishizawa
T, Nagata R, Aoki T, Sakamoto Y, Sugawara Y, Makuuchi M and Kokudo
N: Risk factors of post-operative recurrence and adequate surgical
approach to improve long-term outcomes of hepatocellular carcinoma.
HPB (Oxford). 15:31–39. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang S, He J, Zhang X, Bian Y, Yang L,
Xie G, Zhang K, Tang W, Stelter AA, Wang Q, et al: Activation of
the hedgehog pathway in human hepatocellular carcinomas.
Carcinogenesis. 27:1334–1340. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Della Corte CM, Viscardi G, Papaccio F,
Esposito G, Martini G, Ciardiello D, Martinelli E, Ciardiello F and
Morgillo F: Implication of the Hedgehog pathway in hepatocellular
carcinoma. World J Gastroenterol. 23:4330–4340. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Riobo-Del Galdo NA, Lara Montero A and
Wertheimer EV: Role of Hedgehog signaling in breast cancer:
Pathogenesis and therapeutics. Cells. 8(pii): E3752019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pak E and Segal RA: Hedgehog signal
transduction: Key players, oncogenic drivers and cancer therapy.
Dev Cell. 38:333–344. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jia Y, Wang Y and Xie J: The Hedgehog
pathway: Role in cell differentiation, polarity and proliferation.
Arch Toxicol. 89:179–191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Skoda AM, Simovic D, Karin V, Kardum V,
Vranic S and Serman L: The role of the Hedgehog signaling pathway
in cancer: A comprehensive review. Bosn J Basic Med Sci. 18:8–20.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bürglin TR: The Hedgehog protein family.
Genome Biol. 9:2412008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Machado MV and Diehl AM: Hedgehog
signalling in liver pathophysiology. J Hepatol. 68:550–562. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Finco I, LaPensee CR, Krill KT and Hammer
GD: Hedgehog signaling and steroidogenesis. Annu Rev Physiol.
77:105–129. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Varjosalo M and Taipale J: Hedgehog:
Functions and mechanisms. Genes Dev. 22:2454–2472. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stone DM, Hynes M, Armanini M, Swanson TA,
Gu Q, Johnson RL, Scott MP, Pennica D, Goddard A, Phillips H, et
al: The tumour-suppressor gene patched encodes a candidate receptor
for Sonic hedgehog. Nature. 384:129–134. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hanna A and Shevde LA: Hedgehog signaling:
Modulation of cancer properies and tumor mircroenvironment. Mol
Cancer. 15:242016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ramsbottom SA and Pownall ME: Regulation
of Hedgehog signalling inside and outside the cell. J Dev Biol.
4:232016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pham A, Therond P, Alves G, Tournier FB,
Busson D, Lamour-Isnard C, Bouchon BL, Préat T and Tricoire H: The
Suppressor of fused gene encodes a novel PEST protein involved in
Drosophila segment polarity establishment. Genetics. 140:587–598.
1995.PubMed/NCBI
|
|
25
|
Zhang Z, Shen L, Law K, Zhang Z, Liu X,
Hua H, Li S, Huang H, Yue S, Hui CC and Cheng SY: Suppressor of
fused chaperones gli proteins to generate transcriptional responses
to sonic Hedgehog signaling. Mol Cell Biol. 37:e00421–00416. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Niewiadomski P, Niedziółka SM, Markiewicz
Ł, Uśpieński T, Baran B and Chojnowska K: Gli proteins: Regulation
in development and cancer. Cells. 8:1472019. View Article : Google Scholar
|
|
27
|
Katoh Y and Katoh M: Hedgehog target
genes: Mechanisms of carcinogenesis induced by aberrant hedgehog
signaling activation. Curr Mol Med. 9:873–886. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Che L, Yuan YH, Jia J and Ren J:
Activation of sonic hedgehog signaling pathway is an independent
potential prognosis predictor in human hepatocellular carcinoma
patients. Chin J Cancer Res. 24:323–331. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jeng KS, Sheen IS, Jeng WJ, Lin CC, Lin
CK, Su JC, Yu MC and Fang HY: High expression of patched homolog-1
messenger RNA and glioma-associated oncogene-1 messenger RNA of
sonic hedgehog signaling pathway indicates a risk of postresection
recurrence of hepatocellular carcinoma. Ann Surg Oncol. 20:464–473.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dugum M, Hanouneh I, McIntyre T, Pai R,
Aucejo F, Eghtesad B and Zein N: Sonic hedgehog signaling in
hepatocellular carcinoma: A pilot study. Mol Clin Oncol. 4:369–374.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang D, Cao L, Li Y, Lu H, Yang X and Xue
P: Expression of glioma-associated oncogene 2 (Gli 2) is correlated
with poor prognosis in patients with hepatocellular carcinoma
undergoing hepatectomy. World J Surg Oncol. 11:252013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sicklick JK, Li YX, Jayaraman A, Kannangai
R, Qi Y, Vivekanandan P, Ludlow JW, Owzar K, Chen W, Torbenson MS
and Diehl AM: Dysregulation of the Hedgehog pathway in human
hepatocarcinogenesis. Carcinogenesis. 27:748–757. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cheng WT, Xu K, Tian DY, Zhang ZG, Liu LJ
and Chen Y: Role of Hedgehog signaling pathway in proliferation and
invasiveness of hepatocellular carcinoma cells. Int J Oncol.
34:829–836. 2009.PubMed/NCBI
|
|
34
|
Tarocchi M, Polvani S, Marroncini G and
Galli A: Molecular mechanism of hepatitis B virus-induced
hepatocarcinogenesis. World J Gastroenterol. 20:11630–11640. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Arzumanyan A, Sambandam V, Clayton MM,
Choi SS, Xie G, Diehl AM, Yu DY and Feitelson MA: Hedgehog
signaling blockade delays hepatocarcinogenesis induced by hepatitis
B virus X protein. Cancer Res. 72:5912–5920. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pereira Tde A, Witek RP, Syn WK, Choi SS,
Bradrick S, Karaca GF, Agboola KM, Jung Y, Omenetti A, Moylan CA,
et al: Viral factors induce Hedgehog pathway activation in humans
with viral hepatitis, cirrhosis and hepatocellular carcinoma. Lab
Invest. 90:1690–1703. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Choi SS, Bradrick S, Qiang G, Mostafavi A,
Chaturvedi G, Weinman SA, Diehl AM and Jhaveri R: Up-regulation of
Hedgehog pathway is associated with cellular permissiveness for
hepatitis C virus replication. Hepatology. 54:1580–1590. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Y, Chen W, Han C, Zhang J, Song K,
Kwon H, Dash S, Yao L and Wu T: Adult hepatocytes are
hedgehog-responsive cells in the setting of liver injury: Evidence
for smoothened-mediated activation of NF-kappaB/epidermal growth
factor receptor/Akt in hepatocytes that counteract fas-induced
apoptosis. Am J Pathol. 188:2605–2616. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
He G and Karin M: NF-κB and STAT3-key
players in liver inflammation and cancer. Cell Res. 21:159–168.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mills LD, Zhang Y, Marler RJ,
Herreros-Villanueva M, Zhang L, Almada LL, Couch F, Wetmore C,
Pasca di Magliano M and Fernandez-Zapico ME: Loss of the
transcription factor GLI1 identifies a signaling network in the
tumor microenvironment mediating KRAS oncogene-induced
transformation. J Biol Chem. 288:11786–11794. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sarangi A, Valadez JG, Rush S, Abel TW,
Thompson RC and Cooper MK: Targeted inhibition of the Hedgehog
pathway in established malignant glioma xenografts enhances
survival. Oncogene. 28:3468–3476. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Adolphe C, Hetherington R, Ellis T and
Wainwright B: Patched1 functions as a gatekeeper by promoting cell
cycle progression. Cancer Res. 66:2081–2088. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hasanovic A and Mus-Veteau I: Targeting
the multidrug transporter ptch1 potentiates chemotherapy
efficiency. Cells. 7(pii): E1072018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ding X, Yang Y, Han B, Du C, Xu N, Huang
H, Cai T, Zhang A, Han ZG, Zhou W and Chen L: Transcriptomic
characterization of hepatocellular carcinoma with CTNNB1 mutation.
PLoS One. 9:e953072014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Efroni S, Meerzaman D, Schaefer CF,
Greenblum S, Soo-Lyu M, Hu Y, Cultraro C, Meshorer E and Buetow KH:
Systems analysis utilising pathway interactions identifies sonic
hedgehog pathway as a primary biomarker and oncogenic target in
hepatocellular carcinoma. IET Syst Biol. 7:243–251. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chung SI, Moon H, Ju HL, Cho KJ, Kim DY,
Han KH, Eun JW, Nam SW, Ribback S, Dombrowski F, et al: Hepatic
expression of Sonic Hedgehog induces liver fibrosis and promotes
hepatocarcinogenesis in a transgenic mouse model. J Hepatol.
64:618–627. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cai H, Li H, Li J, Li X, Li Y, Shi Y and
Wang D: Sonic hedgehog signaling pathway mediates development of
hepatocellular carcinoma. Tumour Biol. Oct 15–2016.(Epub ahead of
print). View Article : Google Scholar
|
|
48
|
Michelotti GA, Xie G, Swiderska M, Choi
SS, Karaca G, Krüger L, Premont R, Yang L, Syn WK, Metzger D and
Diehl AM: Smoothened is a master regulator of adult liver repair. J
Clin Invest. 123:2380–2394. 2013.PubMed/NCBI
|
|
49
|
Kim Y, Yoon JW, Xiao X, Dean NM, Monia BP
and Marcusson EG: Selective down-regulation of glioma-associated
oncogene 2 inhibits the proliferation of hepatocellular carcinoma
cells. Cancer Res. 67:3583–3593. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lu JT, Zhao WD, He W and Wei W: Hedgehog
signaling pathway mediates invasion and metastasis of
hepatocellular carcinoma via ERK pathway. Acta Pharmacol Sin.
33:691–700. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang YH, Sui XM, Sui YN, Zhu QW, Yan K,
Wang LS, Wang F and Zhou JH: BRD4 induces cell migration and
invasion in HCC cells through MMP-2 and MMP-9 activation mediated
by the Sonic hedgehog signaling pathway. Oncol Lett. 10:2227–2232.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Xu Q, Liu X, Zheng X, Yao Y, Wang M and
Liu Q: The transcriptional activity of Gli1 is negatively regulated
by AMPK through Hedgehog partial agonism in hepatocellular
carcinoma. Int J Mol Med. 34:733–741. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Matsuo N, Shiraha H, Fujikawa T, Takaoka
N, Ueda N, Tanaka S, Nishina S, Nakanishi Y, Uemura M, Takaki A, et
al: Twist expression promotes migration and invasion in
hepatocellular carcinoma. BMC Cancer. 9:2402009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Meng J, Chen S, Han JX, Qian B, Wang XR,
Zhong WL, Qin Y, Zhang H, Gao WF, Lei YY, et al: Twist1 regulates
vimentin through Cul2 circular RNA to promote EMT in hepatocellular
carcinoma. Cancer Res. 78:4150–4162. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Chun HW and Hong R: Significance of the
hedgehog pathway-associated proteins Gli-1 and Gli-2 and the
epithelial-mesenchymal transition-associated proteins Twist and
E-cadherin in hepatocellular carcinoma. Oncol Lett. 12:1753–1762.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Chen JS, Huang XH, Wang Q, Huang JQ, Zhang
LJ, Chen XL, Lei J and Cheng ZX: Sonic hedgehog signaling pathway
induces cell migration and invasion through focal adhesion
kinase/AKT signaling-mediated activation of matrix
metalloproteinase (MMP)-2 and MMP-9 in liver cancer.
Carcinogenesis. 34:10–19. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zeller C, Hinzmann B, Seitz S, Prokoph H,
Burkhard-Goettges E, Fischer J, Jandrig B, Schwarz LE, Rosenthal A
and Scherneck S: SASH1: A candidate tumor suppressor gene on
chromosome 6q24.3 is downregulated in breast cancer. Oncogene.
22:2972–2983. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
He P, Zhang HX, Sun CY, Chen CY and Jiang
HQ: Overexpression of SASH1 inhibits the proliferation, invasion
and EMT in hepatocarcinoma cells. Oncol Res. 24:25–32. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Sun C, Zhang Z, He P, Zhou Y and Xie X:
Involvement of PI3K/Akt pathway in the inhibition of
hepatocarcinoma cell invasion and metastasis induced by SASH1
through downregulating Shh-Gli1 signaling. Int J Biochem Cell Biol.
89:95–100. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kitagawa H, Uyama T and Sugahara K:
Molecular cloning and expression of a human chondroitin synthase. J
Biol Chem. 276:38721–38726. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Tian J, Ling L, Shboul M, Lee H, O'Connor
B, Merriman B, Nelson SF, Cool S, Ababneh OH, Al-Hadidy A, et al:
Loss of CHSY1, a secreted FRINGE enzyme, causes syndromic
brachydactyly in humans via increased NOTCH signaling. Am J Hum
Genet. 87:768–778. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Liu CH, Lan CT, Chou JF, Tseng TJ and Liao
WC: CHSY1 promotes aggressive phenotypes of hepatocellular
carcinoma cells via activation of the hedgehog signaling pathway.
Cancer Lett. 403:280–288. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Merchant AA and Matsui W: Targeting
Hedgehog-a cancer stem cell pathway. Clin Cancer Res. 16:3130–3140.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Jeng KS, Sheen IS, Jeng WJ, Yu MC, Hsiau
HI, Chang FY and Tsai HH: Activation of the sonic hedgehog
signaling pathway occurs in the CD133 positive cells of mouse liver
cancer Hepa 1–6 cells. Onco Targets Ther. 6:1047–1055. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Abou-Shady M, Baer HU, Friess H, Berberat
P, Zimmermann A, Graber H, Gold LI, Korc M and Büchler MW:
Transforming growth factor betas and their signaling receptors in
human hepatocellular carcinoma. Am J Surg. 177:209–215. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Fabregat I and Caballero-Diaz D:
Transforming growth factor-beta-induced cell plasticity in liver
fibrosis and Hepatocarcinogenesis. Front Oncol. 8:3572018.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Steinway SN, Zañudo JG, Ding W, Rountree
CB, Feith DJ, Loughran TP Jr and Albert R: Network modeling of
TGFbeta signaling in hepatocellular carcinoma
epithelial-to-mesenchymal transition reveals joint sonic hedgehog
and Wnt pathway activation. Cancer Res. 74:5963–5977. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Javelaud D, Alexaki VI, Dennler S,
Mohammad KS, Guise TA and Mauviel A: TGF-β/SMAD/GLI2 signaling axis
in cancer progression and metastasis. Cancer Res. 71:5606–5610.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Fan Q, He M, Sheng T, Zhang X, Sinha M,
Luxon B, Zhao X and Xie J: Requirement of TGFbeta signaling for
SMO-mediated carcinogenesis. J Biol Chem. 285:36570–36576. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Katoh Y and Katoh M: Hedgehog signaling,
epithelial-to-mesenchymal transition and miRNA (Review). Int J Mol
Med. 22:271–275. 2008.PubMed/NCBI
|
|
71
|
Giakoustidis A, Giakoustidis D, Mudan S,
Sklavos A and Williams R: Molecular signalling in hepatocellular
carcinoma: Role of and crosstalk among WNT/ss-catenin, Sonic
Hedgehog, Notch and Dickkopf-1. Can J Gastroenterol Hepatol.
29:209–217. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Chong YC, Lim TE, Fu Y, Shin EM,
Tergaonkar V and Han W: Indian Hedgehog links obesity to
development of hepatocellular carcinoma. Oncogene. 38:2206–2222.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Tripathy A, Thakurela S, Sahu MK,
Uthanasingh K, Behera M, Ajay AK and Kumari R: The molecular
connection of histopathological heterogeneity in hepatocellular
carcinoma: A role of Wnt and Hedgehog signaling pathways. PLoS One.
13:e02081942018. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Salaritabar A, Berindan-Neagoe I, Darvish
B, Hadjiakhoondi F, Manayi A, Devi KP, Barreca D, Orhan IE, Süntar
I, Farooqi AA, et al: Targeting Hedgehog signaling pathway: Paving
the road for cancer therapy. Pharmacol Res. 141:466–480. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Dijkgraaf GJ, Alicke B, Weinmann L,
Januario T, West K, Modrusan Z, Burdick D, Goldsmith R, Robarge K,
Sutherlin D, et al: Small molecule inhibition of GDC-0449
refractory smoothened mutants and downstream mechanisms of drug
resistance. Cancer Res. 71:435–444. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Chen JK, Taipale J, Cooper MK and Beachy
PA: Inhibition of Hedgehog signaling by direct binding of
cyclopamine to Smoothened. Genes Dev. 16:2743–2748. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Jeng KS, Sheen IS, Jeng WJ, Yu MC, Tsai
HH, Chang FY and Su JC: Blockade of the sonic hedgehog pathway
effectively inhibits the growth of hepatoma in mice: An in
vivo study. Oncol Lett. 4:1158–1162. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Jeng KS, Jeng CJ, Jeng WJ, Sheen IS, Chang
CF, Hsiau HI, Hung ZH, Yu MC and Chang FY: Sonic hedgehog pathway
inhibitor mitigates mouse hepatocellular carcinoma. Am J Surg.
210:554–560. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Sun Y, Guo W, Ren T, Liang W, Zhou W, Lu
Q, Jiao G and Yan T: Gli1 inhibition suppressed cell growth and
cell cycle progression and induced apoptosis as well as autophagy
depending on ERK1/2 activity in human chondrosarcoma cells. Cell
Death Dis. 5:e9792014. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Wang Y, Han C, Lu L, Magliato S and Wu T:
Hedgehog signaling pathway regulates autophagy in human
hepatocellular carcinoma cells. Hepatology. 58:995–1010. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Lin TL and Matsui W: Hedgehog pathway as a
drug target: Smoothened inhibitors in development. Onco Targets
Ther. 5:47–58. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Wu X, Zhao B, Cheng Y, Yang Y, Huang C,
Meng X, Wu B, Zhang L, Lv X and Li J: Melittin induces PTCH1
expression by down-regulating MeCP2 in human hepatocellular
carcinoma SMMC-7721 cells. Toxicol Appl Pharmacol. 288:74–83. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Chen YJ, Lin CP, Hsu ML, Shieh HR, Chao NK
and Chao KS: Sonic hedgehog signaling protects human hepatocellular
carcinoma cells against ionizing radiation in an autocrine manner.
Int J Radiat Oncol Biol Phys. 80:851–859. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Tsai CL, Hsu FM, Tzen KY, Liu WL, Cheng AL
and Cheng JC: Sonic Hedgehog inhibition as a strategy to augment
radiosensitivity of hepatocellular carcinoma. J Gastroenterol
Hepatol. 30:1317–1324. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Wang Q, Huang S, Yang L, Zhao L, Yin Y,
Liu Z, Chen Z and Zhang H: Down-regulation of Sonic hedgehog
signaling pathway activity is involved in 5-fluorouracil-induced
apoptosis and motility inhibition in Hep3B cells. Acta Biochim
Biophys Sin (Shanghai). 40:819–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Filgueira NA: Hepatocellular carcinoma
recurrence after liver transplantation: Risk factors, screening and
clinical presentation. World J Hepatol. 11:261–272. 2019.
View Article : Google Scholar : PubMed/NCBI
|
